Knowledge Center

Patent / Jan 01, 1966

Tetracycline process

Authors:
  • Ivan Villax
Source:
BE 658387

A newly isolated strain of Streptomyces lusitanus var tetracyclini NCIB 9500 produces tetracycline with no co-production of chlortetracycline in the presence of Cl-. Thus, in a 6000-1. fermentor, with corn-steep medium contg. 1.5 g. NH4Cl/l. the strain produces 11.1 g. tetracycline/l. and no detectable amt. of chlortetracycline.

Also in the Knowledge Center

Related Content

Inspections History

Hovione sites are periodically inspected by the local and external authorities. All sites are FDA approved and with exception of New Jersey site all have EU GMP certificates.

Page
Read more

Hovione partners with Dragonfly Technologies to offer micellar chemistry technology to customers as a sustainable alternative to conventional chemical processes

Press Release / Mar 07, 2024
Article
View

Drug delivery platforms

Hovione has unique capabilities and expertise in solubility enhancement, lung delivery, modified release and taste-masking applications.

Page
Read more